Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2026-01-28 @ 5:13 PM
Study NCT ID:
NCT00003305
Status:
COMPLETED
Last Update Posted:
2014-01-06
First Post:
1999-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Aminopterin in Treating Patients With Refractory Leukemia
Sponsor:
Genzyme, a Sanofi Company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leukemia | View |